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837-5 New Onset Heart Failure in the Community: One- and 
Three-Year Mortality and Risk Factors for go-Day 
Mortality 
Federica De Giuli, Kay-Tee Khaw. PhIlIp A. Poole-Wilson, S. Maugeri Foundation 
IRCCS, Gussago (BS), Italy, University of Cambridge, Cambridge, United Kingdom 
838 Exercise Testing: Predicting Mortality 
Tuesday, April 01, 2003, 8:30 a.m.-10:OO a.m. 
McCormick Place, Room S402 
The aim of the study was to estimate survival and prognostic factors for go-day mortality 
in patients with new diagnosis of heart failure (HF) made by GPs in a population of 
696664 people in the UK. 
Methods: The General Practice Research Database records data of people registered 
with 525 GPs I” the UK. This project analyses the data of patients (245 y) observed from 
1991 to 1994. Incident cases of HF (5006 men, 9044 women) were selected by reviewing 
the whole list of cardiovascular diagnoses and identifying those with a definite stated 
diagnosis of HF. 
Results: The mean (*SD) age in men and women was: 75 y (9) and 79 y (9). l-y and 3-y 
cumulative probabilities of dying were 31% and 50 %, respectively. Survival curves were 
not linear showing a higher mortality in the first 90 days after diagnosis of HF. 16.4% of 
patients died within 90 days after HF diagnosis. The logistics regression analysis showed 
that age, first diagnosis made in hospital, diagnosis of “acute” HF, and concomitant and 
previous diagnosis of ischaemic heart disease, hypertension and atrial fibrillation - but 
not gender neither concomitant and previous diagnosis of diabetes and COPD - were 
prognostic factors for dying within 90 days from the diagnosis of HF. These data show 
that patients with a new diagnosis of HF made by GPs are severe cases and are affected 
by high mortality in the first 90 days after diagnosis as demonstrated in previous studies 
conducted in patients with HF diagnosis made according to strict criteria. Gender and 
diabetes-that are usual prognostic factors for long-term mortality in HF patients-do not 
seem to affect go-day mortality in this population. 
8:30 a.m. 
838-l Early Repolarization, Heart Rate Recovery, and Risk of 
Death 
Gian M. Novaq Eugene H. Blackstone, Claire E. Pothier, Michael S. Lauer, The 
Cleveland Clinic Foundation, Cleveland, OH 
Background: Early repolarization (EREPOL) has been asscciated with improved auto- 
nomic balance and better prognosis. Heart rate recovery (HRR) after exercise is a 
marker of parasympathetic tone. The associations of EREPOL with HRR and nsk of 
death after accounting for HRR is not known. 
Methods: We followed 24,511 patients referred for treadmill exercise testing and who 
did not have heart’failure, atrial fibrillation, valve disease, pacemakers, Q waves, bundle 
branch block, or ECG LV hypertrophy. We used propensity analysis to account for differ- 
ences in baseline characteristics. 
9:45 a.m 
Results: EREPOL was present in 1424 patients (6%). who were younger (47 vs 55 
years, P < 0.0001) and more likely to be men (89% vs 66%. P < 0.0001). They were less 
likely to have an abnormal HRR (10% vs 20%. P < 0.0001) and to manifest Impaired 
physical fitness (16% vs 26%. P < 0.0001). We successfully matched 1419 of these 
patients to 1419 patients without EREPOL on 39 variables. In this propensity-matched 
population, the overall mortality rate was low, with 69 deaths (3%) during 6.5 years. ERE- 
POL was associated with a lower risk (Figure). 
837-8 Decreasing One-Year Mortality From Heart Failure in 
Sweden: Data From the Swedish Hospital Discharge 
Registry-1998 to 2000 
Karl Swedberq Max Kbster. Mlns RosBn. Maria Schaufelberger, Annika Rosengren. 
Sahlgrenska University Hospital/&tra, GMeborg. Sweden, National Board of Health and 
Welfare, Stockholm, Sweden 
Background: In the last lo-15 years several treatment modalities have demonstrated 
improved prognosis in heart failure in selected study populations. Linle is known whether 
this has translated into Improved prognosis for the patient population at large. We con- 
ducted a sulvey of trends in l-year prognosis of patients treated for heart failure in Swe- 
den over the years 1966 to 2000. 
Methods: Data from the Swedish Hospital Discharge and the Swedish Cause of Death 
registers were used. The study population consisted of all patients aged 55 to 84 
(n=140,087) discharged with a principal diagnosis of heart failure from any Swedish hos- 
pital in 19 Swedish counties (60 per cent of the Swedish population) with complete cover- 
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The decrease was particularly evident from 1994-95. 
The reduction in mortality was probably not due to milder cases being admitted since 
admissions for heart failure also decreased during the period. 
Conclusion : One-year survival after hospital discharge for heart failure has improved 
markedly during the last decade. The improvement coincides with the establishment of 
ACE-inhibitors and beta-blockers as beneficial pharmacological therapies. These bene- 
fits may now also translate into non-study populations. 
After adjusting for propensity score, age, gender, HRR, and functional capacity, EREPOL 
was marginally associated with lower risk (adjusted hazard ratio 0.65, 95% Cl 0.42-1.00, 
P=O.O5). 
Conclusions: Among patients referred for exercise testing, EREPOL is associated with 
a favorable risk profile and a lower likelihood of an abnormal HRR. As an independent 
marker, it is weakly predictive of lower risk. 
8:45 a.m. 
838-2 The Incremental Prognostic Value of the Chronotropic 
Index and Impaired Heart Rate Recovery for Prediction 
of Cardiac Death 
Babak Azarbal, Sean W. Hayes, Rory Hachamovitch, Daniel S. Berman, Cedars-Sinai 
Medical Center, Los Angeles, CA 
Background: Impaired heart rate (HR) response to exercise, measured by the chrono- 
tropic index (Cl), and abnormal heart rate recovery (HRR) are known predictors of car- 
diac death (CD). We examined whether Cl and HRR add incremental value for predicting 
CD in pts undergoing exercise myocardial perfusion SPECT (MPS). 
Methods 10,830 consecutive pts with no valvular disease and not on p blockers under- 
went symptom-limited exercise MPS; 609 pts were censored for early revascularization 
(<60 days). Cl was defined as (peak HR - rest HR)/(PPO-age-rest HR), with ClcO.8 
defined as low. HRR was defined as peak HR - recovery HR. A HRR 5 22 bpm at 2 min 
post peak exercise was considered abnormal. Analysis was performed using survival 
modeling. 
Results There were 93 CD during a mean follow-up of 719+ 252 days (98% complete). 
of 10.021 pts, 1753 (17.5%) had abnormal HRR, 2956 (29.5%) had low Cl, and 733 
(24.6%) had both. In a multivariate model of all univariate predictors of CO, the indepen- 
dent predictors were MPS extent/severity, ~~54.0; age, x=23.3; Cl, x=10.6: HRR. x=5.2. 
The figure shows the observed relationship between Cl, 2 min HRR, and CD. At 2 yrs, 
pts with normal Cl and HRR (A) had a very low risk of CD (0.4%). Pts with either an 
abnormal HRR (B) or a low Cl (C) had increased risk for CD (1.2% and 1.3%, respec- 
tively), and pts with both an abnormal HRR and a low Cl (D) carried the highest risk for 
